MLAB 2401: Clinical Chemistry Keri Brophy-Martinez Lipids and Lipoproteins Assessment.

19
MLAB 2401: Clinical Chemistry Keri Brophy-Martinez Lipids and Lipoproteins Assessment

Transcript of MLAB 2401: Clinical Chemistry Keri Brophy-Martinez Lipids and Lipoproteins Assessment.

Page 1: MLAB 2401: Clinical Chemistry Keri Brophy-Martinez Lipids and Lipoproteins Assessment.

MLAB 2401: Clinical ChemistryKeri Brophy-Martinez

Lipids and LipoproteinsAssessment

Page 2: MLAB 2401: Clinical Chemistry Keri Brophy-Martinez Lipids and Lipoproteins Assessment.

Specimen Collection for Lipid Analysis

• Serum• Fasting

– 12 hour fast preferred– Avoid lipemia

• Presence of fat droplets suspended in a solution.

• Lipemia affects assays by affecting absorbance due to refraction of light

Page 3: MLAB 2401: Clinical Chemistry Keri Brophy-Martinez Lipids and Lipoproteins Assessment.

3

High plasma lipid concentrations can cause excessive plasma turbidity and interfere withspectrophotometric methods.

Lipoproteins can be spundown in this special centrifuge.

Plasma is placed insidethe “donut.” Lipids spin tothe outside of the donut.

Ultracentrifuge

Page 4: MLAB 2401: Clinical Chemistry Keri Brophy-Martinez Lipids and Lipoproteins Assessment.

Lipid Measurement

• Can be ordered as a panel– Includes total, LDL and HDL cholesterol and

triglycerides

Page 5: MLAB 2401: Clinical Chemistry Keri Brophy-Martinez Lipids and Lipoproteins Assessment.

5

Historical Total Cholesterol Methodologies

• Colorimetric measurement procedures are less costly but are subject to interfering substances and may require extraction steps and strong acids

• Classical method = Liebermann-Burchard– Involved extraction & hydrolysis. Uses sulfuric

& acetic acids– Results in formation of a green color,

proportional to the cholesterol concentration

Page 6: MLAB 2401: Clinical Chemistry Keri Brophy-Martinez Lipids and Lipoproteins Assessment.

6

Cholesterol Methodology

Cholesterol ester Free cholesterol + Fatty Acid

Free cholesterol H2O2

H2O2 + Chromogen Colored Chromogen

Cholesterol-Esterase

Cholesterol Oxidase

Horseradish Peroxidase

Three step process using a coupled reaction with cholesterol oxidase.

Page 7: MLAB 2401: Clinical Chemistry Keri Brophy-Martinez Lipids and Lipoproteins Assessment.

7

Cholesterol Measurement• Factors affecting cholesterol levels

– Anything that affects HDL & LDL levels will affect cholesterol concentration-because these lipoprotein contain increased cholesterol

– Thyroxine level inversely affects cholesterol level• hypothyroid associated with hyper cholesterol• hyper thyroid associated with hypo cholesterol

– Estrogens• documented that post-menopausal women have increased LDL

cholesterol– Pregnancy

• altered endocrine function resulting in increased cholesterol– Others include hepatitis, nephrotic syndrome, emotional stress, and

diabetes mellitus

Page 8: MLAB 2401: Clinical Chemistry Keri Brophy-Martinez Lipids and Lipoproteins Assessment.

8

Total Cholesterol Reference Range

• varies with age, sex, & diet– < 200 mg/dL

Page 9: MLAB 2401: Clinical Chemistry Keri Brophy-Martinez Lipids and Lipoproteins Assessment.

HDL Methodology

• Methods– Precipitation Reaction

• Dextran sulfate or phosphotungsate acid with magnesium chloride precipitates LDL and VLDL lipoproteins

• HDL left in the supernatant is tested using cholesterol assay. The answer represents the amount of HDL in the sample

Page 10: MLAB 2401: Clinical Chemistry Keri Brophy-Martinez Lipids and Lipoproteins Assessment.

Precipitation Method

• Drawbacks– Elevated triglyceride levels

• Results in overestimation of HDL• Many labs will not perform

HDL testing when triglyceride concentrations exceed 400 mg/dL

Page 11: MLAB 2401: Clinical Chemistry Keri Brophy-Martinez Lipids and Lipoproteins Assessment.

HDL Methodology

• Homogeneous Reaction• Detergents or enzymes binds sites of VLDL and LDL

particles. HDL is then left to react with colored products and can be measured

• Disadvantages- lacks specificity for HDL

Page 12: MLAB 2401: Clinical Chemistry Keri Brophy-Martinez Lipids and Lipoproteins Assessment.

HDL Reference Range

• Desirable range– > 60 mg/dL

• Gray area– 40-59 mg/dL

• High risk– < 40 mg/dL

Page 13: MLAB 2401: Clinical Chemistry Keri Brophy-Martinez Lipids and Lipoproteins Assessment.

Triglyceride Measurement

• Methods– Enzymatic– Colorimetric

• Involve the liberation of glycerol by lipase

13

Page 14: MLAB 2401: Clinical Chemistry Keri Brophy-Martinez Lipids and Lipoproteins Assessment.

Triglyceride Reference Range

• Recommended– < 150 mg/dL

• Borderline high– 150-199 mg/dL

• High– 200-499 mg/dL

• Very high– > 500 mg/dL

Page 15: MLAB 2401: Clinical Chemistry Keri Brophy-Martinez Lipids and Lipoproteins Assessment.

LDL Measurement

• Direct measurement of LDL (VAP test) is uncommon

• Friedewald estimation ( calculation )

• Test: Total Cholesterol, Total Triglycerides and HDL with routine procedure

• Estimate the LDL with the following :LDL= Chol- (HDL + VLDL)

VLDL= Triglycerides/5

15

Page 16: MLAB 2401: Clinical Chemistry Keri Brophy-Martinez Lipids and Lipoproteins Assessment.

Example of Friedewald Formula

• Susan’s Lipid Panel results are:– Total cholesterol= 230 mg/dL– Triglyceride= 120 mg/dL– HDL= 25 mg/dL

• First: calculate the VLDL– Trig/5= 120/5= 24

• Second: Plug results into formula– LDL= 230- (25+24)– LDL= 181 mg/dL

Page 17: MLAB 2401: Clinical Chemistry Keri Brophy-Martinez Lipids and Lipoproteins Assessment.

More on VAP

• VAP= vertical auto profile• Advantages

– Directly measures LDL, and other classes of lipoproteins

– Can be performed on non-fasting samples– Identifies those at high risk for CAD

• Disadvantages– Not routinely ordered by physicians

Page 18: MLAB 2401: Clinical Chemistry Keri Brophy-Martinez Lipids and Lipoproteins Assessment.

18

Lipids in Stool

– Normal adult with normal diet will not have more than 6 grams /day in feces.

– Increased levels seen in children with malabsorption and adults with pancreatic insufficiency.

– Testing done on 72 hour collection of stool. Lipid content determined as percentage of entire mass.

Page 19: MLAB 2401: Clinical Chemistry Keri Brophy-Martinez Lipids and Lipoproteins Assessment.

References

• Bishop, M., Fody, E., & Schoeff, l. (2010). Clinical Chemistry: Techniques, principles, Correlations. Baltimore: Wolters Kluwer Lippincott Williams & Wilkins.

• http://chemi-girls.blog.com/page/2/• http://www.synermedinc.com/revolution.php• http://www.vetlab.com/Lipoclear.htm• Shokrani, M. (2014, January). Emerging approaches to the

examination of lipoprotiens for cardio-metabolic risk stratification. MLO, 46(1), 16-17.

• Sunheimer, R., & Graves, L. (2010). Clinical Laboratory Chemistry. Upper Saddle River: Pearson .